Evidence map›Paper›PMID 30754983›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Utilization of Anticoagulants in Nonvalvular Atrial Fibrillation Before and After Catheter Ablation at Shanghai, China.

Chen Tingting, Wang Yuzhu, Zhang Lin, Li Ran, Li Jing, Wu Yi, Li Xiaoyu, Lv Qianzhou

Open access · goldAbstract read
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Chen Tingting1 Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0003-0197-1987
Wang Yuzhu1 Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang Lin1 Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.
Li Ran1 Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.
Li Jing1 Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.
Wu Yi1 Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.
Li Xiaoyu1 Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.
Lv Qianzhou1 Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.
Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both vitamin K antagonists (VKAs) and novel oral anticoagulants (NOACs) are effective for stroke prevention in nonvalvular atrial fibrillation (NVAF) patients. This study evaluated the utilization of VKA and NOACs in NVAF patients before and after catheter ablation in China. Prescription data were retrospectively collected between January 1, 2016, and December 31, 2016, including indication of use, dose, renal function, and risk assessment (CHA

Indexed as

AdultAgedAged, 80 and overAnticoagulantsAtrial FibrillationCatheter AblationChinaFemaleHumansMaleMiddle AgedYoung AdultAnticoagulantsanticoagulant utilizationatrial fibrillationnovel oral anticoagulantwarfarin

Identifiers

PMID30754983
PMCPMC6714957
OpenAlexW2911714348

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.